Skip to main content

Evolutionary Genomics Receives NSF Phase I SBIR Grant

NEW YORK, June 6 - Evolutionary Genomics has received a Phase I Small Business Innovative Research grant from the National Science Foundation, the company said on Wednesday.


The company is planning to use the grant to find genes that protect chimpanzees from developing AIDS when infected with HIV by comparing equivalent genes of humans and chimpanzees.


Evolutionary Genomics, located in FitzsimonsBioscienceParkCenter in Aurora, Colo., has developed a patented method for comparing genes of closely related species and identifying those responsible for adaptations. It applies this method both to human healthcare and agriculture.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.